News

Cornelia Tischmacher with her medical team in Chicago.
Researchers have developed an innovative dual-receptor T-cell therapy that promises safer and more effective cancer ...
OmRx Oncology begins phase 2 trial of oral PD-L1 inhibitor OX-4224 in patients with non-small cell lung cancer: San Diego Saturday, May 10, 2025, 12:00 Hrs [IST] OmRx Oncology, or ...
Michael Hu battled Stage 4 lung cancer that spread to his liver, bones and brain thanks to breakthroughs in research.
Mass General Brigham researchers created an AI tool that uses a simple face photograph to predict how well a patient may fare ...
A new AI model can deduce a person's biological age using a selfie. Could it be used to guide cancer treatment decisions?
Patients older than 65 years had similar clinical outcomes in response to immune checkpoint inhibitors as younger patients with cancer.
A single blood test, designed to pick up chemical signals indicative of the presence of many different types of cancer, could ...
A study of human tumor cells implanted in mice from the MacPherson Lab at Fred Hutch describes a new way to screen for the ...
A single blood test, designed to pick up chemical signals indicative of the presence of many different types of cancer, could ...
The escalating burden of lung, breast, and gastric cancers across Asia presents a pressing public health challenge, compounded by the region’s vast ...
A new study presented at ESTRO 2025 introduces the RAPID-RT study, which uses an innovative rapid-learning approach to ...